title: [The metabolic syndrome: where are we going and for what benefits?].
abstract: The metabolic syndrome is found in 25-30 % of the German population over the age of 40 years. The concept of metabolic syndrome makes possible an all-inclusive diagnosis and treatment of a bundle of diseases. Prevention of this syndrome is essential if a further rise in the incidence of type 2 diabetes mellitus and coronary heart disease is to be prevented. Building on a "common soil" for the disease components, optimal treatment can be provided and side effect as well as costs reduced.
authors.affiliation: Zentrum für Klinische Studien, Forschungsbereich Endokrinologie und Stoffwechsel, GWT, Technische Universität Dresden GmbH, Dresden, Germany. hanefeld@gwtonline-zks.de
authors.forename: M
authors.initials: M
authors.lastname: Hanefeld
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control; D019033:Delivery of Health Care, Integrated; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008019:Life Style; D024821:Metabolic Syndrome / Q000453:epidemiology* / Q000378:metabolism / Q000517:prevention & control* / Q000628:therapy; D009765:Obesity / Q000453:epidemiology* / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy